DLDean Y. Li

Dean Y. Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dean Y. Li has a total of 325 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Abstract 75: Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth

    by Romuald Girard, Hussein A Zeineddine, Maged D Fam, Ying Cao, Changbin Shi, Thomas Moore, Rhonda Lightle, Agnieszka Stadnik, Robert Shenkar, Sean P Polster, et al.

    Introduction: The clinical course of cerebral cavernous malformations (CCMs) is highly unpredictable, with a limited number of cross sectional studies correlating pro-inflammatory genotypes and plasma biomarkers with prior disease severity. We hereby hypothesize that a panel of plasma biomarkers, with reported role in the physiopathology of CCM, may predict subsequent clinically relevant disease activity. Methods: This was a single-site prospective observational cohort study, without planned intervention. Non-fasting peripheral venous blood samples from 55 patients (25 with sporadic and 30 with familial CCM) were collected. Twenty-four plasma biomarkers were quantified and analyzed regarding their predictive association with the occurrence of a symptomatic hemorrhage or lesional growth within a year following the blood sample. We generated the receiver operating characteristic (ROC) curves and area under curves (AUC) for each biomarker individually and for each weighted linear combination of relevant biomarkers. The best model to predict lesional activity was selected as that minimizing the Akaike Information Criterion (AIC), representing parsimonious model offering the best fit to the data with the fewest number of predictors. Results: Eleven patients experienced lesional activity events (5 symptomatic bleeds and 10 lesional growths) within a year after the blood draw. These patients had lower levels of CD14 (p=0.05), IL6 (p=0.04), ROBO4 (p=0.03) and VEGF (p=0.0003), along with higher IL1β (p=0.008) plasma levels. Among the 35 weighted linear combinations of these 5 biomarkers, the best model (with the lowest AIC value=25.3), was the combination including CD14, IL1β, VEGF and ROBO4, predicting a symptomatic bleed or lesional growth with a sensitivity of 86% and specificity of 88% (AUC=0.90, pConclusion: This is the first study reporting a predictive association between plasma biomarkers and subsequent CCM disease clinical activity. This may be applied in clinical prognostication, and in the stratification of cases in clinical trials.

  • Cardiac Rotational Mechanics as a Predictor of Favorable Functional and Structural Response After Mechanical Unloading With Cardiac Assist Devices in Advanced Heart Failure Patients

    by Michael J. Bonios, James Wever Pinzon, Josef Stehlik, Abdallah Kfoury, Edward M. Gilbert, Rami Alharethi, Jose Nativi-Nicolau, Craig H. Selzman, Mohammad Alsari, Bruce Reid, et al.


  • Regional Structural Uniformity of Left Ventricular Remodeling in Patients with Advanced Non Ischemic Cardiomyopathy

    by Samuel F. Passi, Nikos A. Diakos, Abdallah G. Kfoury, Craig H. Selzman, Chi-Gang Yen, Bruce B. Reid, Omar Wever-Pinzon, Edward M. Gilbert, Deborah Budge, Jose Nativi-Nicolau, et al.

  • Open Access

    Blocking Fibroblast Growth Factor Receptor Signaling Inhibits Tumor Growth, Lymphangiogenesis, and Metastasis

    by Frédéric Larrieu-Lahargue, Alana L. Welm, Marion Bouchecareilh, Kari Alitalo, Dean Y. Li, Andreas Bikfalvi, Patrick Auguste

    Fibroblast Growth Factor receptor (FGFR) activity plays crucial roles in tumor growth and patient survival. However, FGF (Fibroblast Growth Factor) signaling as a target for cancer therapy has been under-investigated compared to other receptor tyrosine kinases. Here, we studied the effect of FGFR signaling inhibition on tumor growth, metastasis and lymphangiogenesis by expressing a dominant negative FGFR (FGFR-2DN) in an orthotopic mouse mammary 66c14 carcinoma model. We show that FGFR-2DN-expressing 66c14 cells proliferate in vitro slower than controls. 66c14 tumor outgrowth and lung metastatic foci are reduced in mice implanted with FGFR-2DN-expressing cells, which also exhibited better overall survival. We found 66c14 cells in the lumen of tumor lymphatic vessels and in lymph nodes. FGFR-2DN-expressing tumors exhibited a decrease in VEGFR-3 (Vascular Endothelial Growth Factor Receptor-3) or podoplanin-positive lymphatic vessels, an increase in isolated intratumoral lymphatic endothelial cells and a reduction in VEGF-C (Vascular Endothelial Growth Factor-C) mRNA expression. FGFs may act in an autocrine manner as the inhibition of FGFR signaling in tumor cells suppresses VEGF-C expression in a COX-2 (cyclooxygenase-2) or HIF1-α (hypoxia-inducible factor-1 α) independent manner. FGFs may also act in a paracrine manner on tumor lymphatics by inducing expression of pro-lymphangiogenic molecules such as VEGFR-3, integrin α9, prox1 and netrin-1. Finally, in vitro lymphangiogenesis is impeded in the presence of FGFR-2DN 66c14 cells. These data confirm that both FGF and VEGF signaling are necessary for the maintenance of vascular morphogenesis and provide evidence that targeting FGFR signaling may be an interesting approach to inhibit tumor lymphangiogenesis and metastatic spread.


  • Netrin Ligands and Receptors: Lessons From Neurons to the Endothelium

    by Frederic Larrieu-Lahargue, Kirk R. Thomas, Dean Y. Li


  • Netrin-4 Activates Endothelial Integrin α6β1

    by Frederic Larrieu-Lahargue, Alana L. Welm, Kirk R. Thomas, Dean Y. Li

    Rationale:: Netrin-4 regulates vascular development. Identity of netrin-4 endothelial receptor and its subsequent cell functions is controversial. We previously demonstrated that the inhibition of netrin-1 canonical receptors, Unc5B and neogenin, expressed by lymphatic endothelial cells, do not suppress netrin-4-induced cell signaling and functions. Netrin family members were shown to signal through a range of receptors, including integrins (such as α3β1, α6β1, and α6β4) in nonendothelial cells. Objective:: We tested whether integrins are netrin-4 receptors in the endothelium. Methods and Results:: The α6β1 integrin is expressed by endothelial cells, and binds netrin-4 in a dose-dependent manner. Inhibition of α6 or β1 integrin subunits suppresses netrin-4-induced endothelial cell migration, adhesion, and focal adhesion contact. Netrin-4-stimulated phosphorylation of Src kinase family, effectors of endothelial cell migration, is also abolished by α6 or β1 inhibition. Finally, netrin-4 and α6β1 integrin expression colocalize in mouse embryonic, intestine, and tumor vasculature. Conclusions:: The α6β1 integrin is a netrin-4 receptor in lymphatic endothelium and consequently represents a potential target to inhibit netrin-4-induced metastatic dissemination.


  • Open Access

    Hadp1, a newly identified pleckstrin homology domain protein, is required for cardiac contractility in zebrafish

    by Joshua D. Wythe, Michael J. Jurynec, Lisa D. Urness, Christopher A. Jones, M. Khaled Sabeh, Andreas A. Werdich, Mariko Sato, H. Joseph Yost, David J. Grunwald, Calum A. MacRae, et al.

    The vertebrate heart is one of the first organs to form, and its early function and morphogenesis are crucial for continued embryonic development. Here we analyze the effects of loss of Heart adaptor protein 1 (Hadp1), which we show is required for normal function and morphogenesis of the embryonic zebrafish heart. Hadp1 is a pleckstrin homology (PH)-domain-containing protein whose expression is enriched in embryonic cardiomyocytes. Knockdown of hadp1 in zebrafish embryos reduced cardiac contractility and altered late myocyte differentiation. By using optical mapping and submaximal levels of hadp1 knockdown, we observed profound effects on Ca2+ handling and on action potential duration in the absence of morphological defects, suggesting that Hadp1 plays a major role in the regulation of intracellular Ca2+ handling in the heart. Hadp1 interacts with phosphatidylinositol 4-phosphate [PI4P; also known as PtdIns(4)P] derivatives via its PH domain, and its subcellular localization is dependent upon this motif. Pharmacological blockade of the synthesis of PI4P derivatives in vivo phenocopied the loss of hadp1 in zebrafish. Collectively, these results demonstrate that hadp1 is required for normal cardiac function and morphogenesis during embryogenesis, and suggest that hadp1 modulates Ca2+ handling in the heart through its interaction with phosphatidylinositols.


  • Do Ischemic Cardiomyopathy and Cardiac Allograft Vasculopathy Have Unique Myocardial Remodeling Characteristics?

    by Divya Ratan Verma, Stavros G. Drakos, Monica P. Revelo, Abdallah G. Kfoury, Farman Khan, Feras Bader, Deborah Budge, Rami Alharethi, Craig Selzman, Edward Gilbert, et al.

  • A luminescent oxygen channeling biosensor that measures small GTPase activation

    by Björn Niebel, Benjamin Weiche, Alan L. Mueller, Dean Y. Li, Nora Karnowski, Michael Famulok

    We established a homogeneous luminescent oxygen channeling sensor for measuring activation states of small GTPases. The assay quantifies activated GTPases in cell lysates, can be applied to different GTPases, and can be used for multiplex screening. The study will provide guidelines for determining activation states of diverse GTPases in various biological contexts.


  • Robo4-dependent Slit signaling stabilizes the vasculature during pathologic angiogenesis and cytokine storm

    by Nyall R London, Dean Y Li

    Purpose of review The endothelium is bombarded with and must respond to multiple destabilizing proangiogenic and inflammatory cytokines. Recent findings Endogenous cell signaling systems such as Roundabout (Robo)4-dependent Slit signaling are in place to help maintain homeostatic balance and prevent excessive destabilization. Upon Robo4 activation by Slit, paxillin is recruited to the cytoplasmic domain along with an ArfGAP known as GIT1. GIT1 recruitment results in inactivation of Arf6, a protein shown to regulate cadherin cell surface localization. Slit increases vascular endothelial-cadherin presentation at the cell surface and enhances vascular barrier function in the presence of inflammatory cytokines. Summary Through harnessing Robo4-dependent Slit signaling, survival can be enhanced in mouse models of sepsis and avian flu infection. This effect is achieved by blunting the host vascular response to cytokines. Thus, vascular stabilizing programs should be investigated as potential therapeutics for infectious disease characterized by cytokine storm.